scholarly journals Effectiveness of synthetic calcite doped with Fe-EDDHSA as a slow-release Fe source: In-vitro experiment on kiwifruit (Actinidia chinensis var. deliciosa) plants

2019 ◽  
Vol 4 (1) ◽  
pp. 127-135
Author(s):  
Baldi Elena ◽  
◽  
Marino Grazia ◽  
Muzzi Enrico ◽  
Marzadori Claudio ◽  
...  
Molecules ◽  
2021 ◽  
Vol 26 (2) ◽  
pp. 449
Author(s):  
Ahmed M. Omer ◽  
Zyta M. Ziora ◽  
Tamer M. Tamer ◽  
Randa E. Khalifa ◽  
Mohamed A. Hassan ◽  
...  

An effective drug nanocarrier was developed on the basis of a quaternized aminated chitosan (Q-AmCs) derivative for the efficient encapsulation and slow release of the curcumin (Cur)-drug. A simple ionic gelation method was conducted to formulate Q-AmCs nanoparticles (NPs), using different ratios of sodium tripolyphosphate (TPP) as an ionic crosslinker. Various characterization tools were employed to investigate the structure, surface morphology, and thermal properties of the formulated nanoparticles. The formulated Q-AmCs NPs displayed a smaller particle size of 162 ± 9.10 nm, and higher surface positive charges, with a maximum potential of +48.3 mV, compared to native aminated chitosan (AmCs) NPs (231 ± 7.14 nm, +32.8 mV). The Cur-drug encapsulation efficiency was greatly improved and reached a maximum value of 94.4 ± 0.91%, compared to 75.0 ± 1.13% for AmCs NPs. Moreover, the in vitro Cur-release profile was investigated under the conditions of simulated gastric fluid [SGF; pH 1.2] and simulated colon fluid [SCF; pH 7.4]. For Q-AmCs NPs, the Cur-release rate was meaningfully decreased, and recorded a cumulative release value of 54.0% at pH 7.4, compared to 73.0% for AmCs NPs. The formulated nanoparticles exhibited acceptable biocompatibility and biodegradability. These findings emphasize that Q-AmCs NPs have an outstanding potential for the delivery and slow release of anticancer drugs.


2009 ◽  
Vol 27 (2) ◽  
pp. 340-349 ◽  
Author(s):  
Elena Soto ◽  
Sebastian Haertter ◽  
Michael Koenen-Bergmann ◽  
Alexander Staab ◽  
Iñaki F. Trocóniz

1996 ◽  
Vol 27 (5) ◽  
pp. 384-391
Author(s):  
Gholam A Peyman ◽  
Dachuan Yang ◽  
Bahram Khoobehi ◽  
Mohamad H Rahimy ◽  
So Y Chin

2021 ◽  
Vol 22 (5) ◽  
Author(s):  
Zohreh Sadat Rastegar Ramsheh ◽  
Zahra Mohtashami ◽  
Neda Kargar ◽  
Hamid Akbari Javar ◽  
Morteza Rafiee Tehrani ◽  
...  

2019 ◽  
Vol 64 (No. 7) ◽  
pp. 294-301
Author(s):  
S Gonzalez-Munoz ◽  
J Sanchez ◽  
S Lopez-Aguirre ◽  
J Vicente ◽  
J Pinos-Rodriguez

One in vitro assay and one in vivo trial with ruminally cannulated Holstein steers were conducted to evaluate the effects of a dietary substitution of soybean meal by a urea and slow-release urea source of fermentation and degradation of diets for cattle. The experimental diets consisted of the total mixed rations defined as the control with soybean meal (SBM), U (urea), SRU (slow-release urea), and SRU+U+AA (0.42% + 0.42% + 1% amino acids methionine and lysine). The dietary substitution of SBM by U or SRU reduced (P < 0.05) the total gas production (V), microbial mass and degradation at 72 h incubation under the in vitro conditions, as well as the degradation rate (c) and the total volatile fatty acids (VFA) in the rumen of the steers; however, when the dietary substitution of SBM was by U+SRU+AA, those values did not decrease. In the steers, the dietary substitution of SBM by U and SRU reduced the ruminal degradation rate and the total VFA, and increased the ammonia N, but when SBM was substituted by U+SRU+AA in the diets, these changes were not observed. No advantage of SRU over U was found. The dietary substitution of SBM by U, SRU, U+SRU+AA did not modify the molar proportion of the VFA in the rumen nor were there changes in the nutrient digestion or excretion. Both the in vitro assay and the in vivo trial indicated that replacing SBM with U or SRU increases the ruminal ammonia N concentrations and reduces the degradation rate in the rumen, although those undesirable findings were not found when the SBM was replaced by U+SRU+AA. Therefore, it is feasible to replace the SBM with a combination of urea, slow-release urea, lysine and methionine in the diet for the ruminants.


2015 ◽  
Vol 27 (1) ◽  
pp. 229
Author(s):  
T. G. B. Rodrigues ◽  
E. M. Pioltine ◽  
E. M. Razza ◽  
M. F. G. Nogueira

Liposomes and nanocapsules (NC) are nanotechnologies that allow for controlled drug-release systems, providing slow release of the incorporated or adsorbed substance in the lipid or polymeric particle. Therefore, slow-release FSH-loaded nanocapsules could be an innovative tool for the improvement of production systems. We aimed to evaluate the embryotoxicity of the NC (the vehicle without any incorporation) and analyse the effectiveness of FSH release through the addition of NC to in vitro maturation (IVM). Cumulus-oocyte complexes (COC, grades I and II) from follicles ranging 3 to 8 mm were obtained from bovine ovaries from abattoir. Ten to 20 COC were washed in TCM199 hepes medium droplets and, subsequently, in droplets through the specific group to which they were allocated. In experiment 1 (E1), 6 groups (G1, G2, G3, G4, G5, and G6; 5 replicates, n = 76 oocytes/group) were defined: G1 = negative control [1 mL of TCM199 bicarbonate, 5 μL of amikacin (16.67 μg μL–1), 2 μL of pyruvate (0.011 g mL–1)], G2 = experimental control [5 mL of TCM199 bicarbonate, 0.030 g of BSA, 5 μL of FSH (0.1 mg mL–1), 25 μL of amikacin (16.67 mg μL–1), 10 μL of pyruvate (0.011 g mL–1)], G3 = laboratory control [0.9 mL of G2, 100 mL of FCS, 10 μL of LH (50 μg mL–1), and 1 μL of oestradiol] and groups G4, G5, and G6 contained 0.9 mL of G2 plus different concentrations of empty NC: 10% (~0.1 g), 1%, and 0.1% vol/vol, respectively. In the second experiment (E2), we used the same groups, but now groups G4 to G6 were supplemented with FSH derived from NC loaded with FSH (5 replicates, n = 98 oocytes/group). The NC was produced by the coacervation method containing grape seed oil, propylene glycol, isopropyl myristate, and Tween 20 in mixture to the aqueous phase with atelocollagen and xanthan gum. The NC were submitted to sonication and produced without any active compounds for the E1 and incorporated with FSH (10 μg mL–1) for E2. There was a clear morphological difference (expansion) in cumulus cells after IVM (method according to Ali and Sirard 2002 Biol. Reprod. 66, 901–905). Data were analysed with ANOVA and post-hoc Tukey-Kramer. There was no expansion in G1, but cumulus in G2 and G3 expanded as expected (for both experiments). In both E1 and E2 there was partial expansion in G4 while G5 showed full expansion, similar to G2 and G3. Expansion of G6 was fair in E1, but in E2 the G6 expansion was similar to G1 (not expanded). In E1, cleavage (D3) rates of the highest tested concentration of NC [G4 (36.6%)] was different from G2 (72.1%), G3 (68.7%), G5 (59.3%), and G6 (69.5%; P < 0.001). Also in E2, cleavage rates of G4 (28.5%) differed from G2 (61.8%), G3 (77.2%), and G5 (64.9%). The blastocyst production did not differ between groups in E1 (P > 0.1). In E2, the group with the highest concentration of NC tested [G4 (9.5%)] and the control group [G2 (19.5%)] had different blastocyst rates (P < 0.05). Our results suggest a potential toxic effect for the pre-implantation embryo after using NC on the IVM of bovine oocytes.Authors acknowledge funding from grants #12/50533-2, #13/05083-1, #12/24423-5, #13/07730-4, São Paulo Research Foundation (FAPESP).


2017 ◽  
Vol 78 (6) ◽  
pp. 677-687 ◽  
Author(s):  
Delphine Laniesse ◽  
Dale A. Smith ◽  
Heather K. Knych ◽  
Cornelia Mosley ◽  
David Sanchez-Migallon Guzman ◽  
...  

2012 ◽  
Vol 499 ◽  
pp. 99-103
Author(s):  
Jun Chang ◽  
Cheng Wu Li ◽  
Gang Li

A series of polyesters containing 5-fluorouracil in the main chain were prepared by reacting potassium salt of 5-fluorouracil with different molecular weight ω-chloroalkyl chloroacetyl esters.The copolymers were characterized by FT-IR, 1H-NMR, VPO and UV spectroscopy. The drug release profile in vitro of the copolymers were studied, the results showed prodrug could slow release 5-FU or 5-FU units in different solution, they may be likely to become potential antitumor prodrug.


Sign in / Sign up

Export Citation Format

Share Document